On Wednesday, August 26th 2015, the National Institutes of Health (NIH) announced the release of its revised Priority List of Needs in Pediatric Therapeutics for 2015. The Best Pharmaceuticals for Children Act of 2002 requires that the NIH, in consultation with the Food and Drug Administration and experts in pediatric research, identify the drugs and therapeutic areas of highest priority for study in pediatric populations. The list is organized by therapeutic area, which can be a group of conditions, a subgroup of the population, or a setting of care. BPCA legislation requires the NIH to update the priority list every three years.
To view the Federal Register Notice and background:
To view the 2015 Priority List of Needs in Pediatric Therapeutics: